News
AstraZeneca reveals $50bn investment in US facilities
Trump's pharma tariffs haven't appeared yet, but AstraZeneca has joined several of its peers with big investments in US manufacturing and R&D.
News
Sarepta backs down and pauses Elevidys shipments
The FDA seems to have won its staring contest with Sarepta over shipments of Elevidys, as the company blinks and agrees to a pause from today.
News
FDA names a new CDER director, choosing a biotech vet
The FDA has rounded out its senior leadership by naming biopharma industry executive George Tidmarsh to the role of CDER director.
News
Merck's SpringWorks takeover delivers a drug approval
Merck gets another quick return on its $3.9bn SpringWorks takeover with EU approval of Ezmekly for tumours caused by neurofibromatosis type 1.
News
Sarepta resists as FDA seeks pause on Elevidys use
Sarepta has defied an FDA request to halt all use of its gene therapy for Duchenne muscular dystrophy, creating an intriguing regulatory impasse.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
